Literature DB >> 14730409

Dominantly inherited progressive pseudorheumatoid dysplasia with hypoplastic toes.

Ivo Marik1, Olga Marikova, Dana Zemkova, Miroslav Kuklik, Kazimierz Kozlowski.   

Abstract

OBJECTIVE: To present four related patients with progressive pseudorheumatoid dysplasia (PPsRD) each with distinctive history, unique phenotype and some peculiar radiographic findings. RESULTS AND
CONCLUSIONS: The history was characterised by weather-dependent articular pain. The unique phenotypic features were hypoplasia/dysplasia of one or two toes. Peculiar radiographic findings were hypoplasia of the 3rd and 4th metatarsals, platyspondyly with rectangular shape of the lumbar spinal canal, progressive narrowing of the joint spaces and early synovial chondromatosis. Finally, the condition was inherited as a dominant trait. This constellation of abnormalities constitutes a distinct form of PPsRD. PPsRD must be differentiated from other bone dysplasias, specifically spondyloepiphyseal dysplasias, autosomal dominant spondylarthropathy, juvenile rheumatoid arthritis and osteoarthritis.

Entities:  

Mesh:

Year:  2004        PMID: 14730409     DOI: 10.1007/s00256-003-0708-z

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  13 in total

Review 1.  Progressive pseudorheumatoid dysplasia: report of a family and review.

Authors:  H E el-Shanti; H Z Omari; H I Qubain
Journal:  J Med Genet       Date:  1997-07       Impact factor: 6.318

2.  Radiographic features of progressive pseudorheumatoid arthritis.

Authors:  K Kozlowski; J Kennedy; I C Lewis
Journal:  Australas Radiol       Date:  1986-08

3.  Spondyloepiphyseal dysplasia tarda with progressive arthropathy: a rare disorder frequently diagnosed among Arabs.

Authors:  A S Teebi; S A Al Awadi
Journal:  J Med Genet       Date:  1986-04       Impact factor: 6.318

4.  Progressive pseudorheumatoid arthritis of childhood (PPAC) and normal adult height.

Authors:  E Legius; M Mulier; B Van Damme; J P Fryns
Journal:  Clin Genet       Date:  1993-09       Impact factor: 4.438

5.  Progressive pseudorheumatoid chondrodysplasia: a report of nine cases in three families.

Authors:  H Rezai-Delui; G Mamoori; E Sadri-Mahvelati; N M Noori
Journal:  Skeletal Radiol       Date:  1994-08       Impact factor: 2.199

6.  Spondylo-epiphysial dysplasia tarda with progressive arthropathy. A "new" disorder of autosomal recessive inheritance.

Authors:  R Wynne-Davies; C Hall; B M Ansell
Journal:  J Bone Joint Surg Br       Date:  1982

7.  Spondyloepiphyseal dysplasia tarda with progressive arthropathy.

Authors:  S A Al-Awadi; T I Fårag; K Naguib; M Y El-Khalifa; A Cuschieri; G Hosny; M Zahran; A G Al-Ansari
Journal:  J Med Genet       Date:  1984-06       Impact factor: 6.318

8.  Progressive pseudorheumatoid arthritis of childhood (PPAC). A hereditary disorder simulating rheumatoid arthritis.

Authors:  J Spranger; C Albert; F Schilling; C Bartsocas; H Stöss
Journal:  Eur J Pediatr       Date:  1983-03       Impact factor: 3.183

9.  [Spondylo-epiphyseal dysplasia tarda with progressive arthropathy: description of a patient whose mother showed minimal features of the disease].

Authors:  A Rasore-Quartino; A Camera; G Camera
Journal:  Pathologica       Date:  1993 Mar-Apr

10.  Spondyloepiphyseal dysplasia tarda with progressive arthropathy.

Authors:  N Kaibara; K Takagishi; I Katsuki; M Eguchi; S Masumi; A Nishio
Journal:  Skeletal Radiol       Date:  1983       Impact factor: 2.199

View more
  9 in total

1.  Novel COL2A1 variant (c.619G>A, p.Gly207Arg) manifesting as a phenotype similar to progressive pseudorheumatoid dysplasia and spondyloepiphyseal dysplasia, Stanescu type.

Authors:  Julie Jurgens; Nara Sobreira; Peggy Modaff; Catherine A Reiser; Soo Hyun Seo; Moon-Woo Seong; Sung Sup Park; Ok Hwa Kim; Tae-Joon Cho; Richard M Pauli
Journal:  Hum Mutat       Date:  2015-08-06       Impact factor: 4.878

Review 2.  Progressive pseudorheumatoid dysplasia: a rare childhood disease.

Authors:  Sofia Torreggiani; Marta Torcoletti; Belinda Campos-Xavier; Francesco Baldo; Carlo Agostoni; Andrea Superti-Furga; Giovanni Filocamo
Journal:  Rheumatol Int       Date:  2018-10-16       Impact factor: 2.631

3.  Progressive pseudorheumotoid dysplasia: A presentation of four cases with slow and rapid progression and effects of early rehabilitation program.

Authors:  Esra Giray; İlker Yağcı; Huriye Nursel Elçioğlu
Journal:  Turk J Phys Med Rehabil       Date:  2019-01-29

4.  Delayed-onset progressive pseudorheumatoid dysplasia with secondary synovial chondromatosis.

Authors:  Pratyush Shahi; Apoorv Sehgal; Aarushi Sudan; Shreya Sehgal
Journal:  BMJ Case Rep       Date:  2020-05-18

5.  Progressive Pseudorheumatoid Dysplasia Misdiagnosed as Seronegative Juvenile Idiopathic Arthritis.

Authors:  Ozgur Taspinar; Fatih Kelesoglu; Yasar Keskin; Murat Uludag
Journal:  Ethiop J Health Sci       Date:  2016-07

6.  WISP3 mutational analysis in Indian patients diagnosed with progressive pseudorheumatoid dysplasia and report of a novel mutation at p.Y198.

Authors:  V Madhuri; M Santhanam; K Rajagopal; L K Sugumar; V Balaji
Journal:  Bone Joint Res       Date:  2016-07       Impact factor: 5.853

7.  Clinical and Molecular Characterization and Discovery of Novel Genetic Mutations of Chinese Patients with COL2A1-related Dysplasia.

Authors:  Yang Xu; Li Li; Chun Wang; Hua Yue; Hao Zhang; Jiemei Gu; Weiwei Hu; Lianyong Liu; Zhenlin Zhang
Journal:  Int J Biol Sci       Date:  2020-01-16       Impact factor: 6.580

8.  Early childhood presentation of Czech dysplasia.

Authors:  Lindsay C Burrage; James T Lu; David S Liu; Timothy J Moss; Richard Gibbs; Alan E Schlesinger; Carlos A Bacino; Philippe M Campeau; Brendan H Lee
Journal:  Clin Dysmorphol       Date:  2013-04       Impact factor: 0.816

9.  Ischiopubic and odontoid synchondrosis in a boy with progressive pseudorheumatoid chondrodysplasia.

Authors:  Ali Al Kaissi; Farid Ben Chehida; Maher Ben Ghachem; Franz Grill; Klaus Klaushofer
Journal:  Pediatr Rheumatol Online J       Date:  2007-09-27       Impact factor: 3.054

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.